title: Factors Associated With Discontinuation of Sulfonylurea Therapy In Type 2 Diabetes Patients Who Initiate Insulin.
authors.affiliation: Merck Sharp & Dohme, Oeiras, Portugal.
authors.forename: P
authors.initials: P
authors.lastname: Laires
authors.affiliation: Georgetown University, Washington, DC, DC, USA.
authors.forename: A Z
authors.initials: AZ
authors.lastname: Fu
authors.affiliation: Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
authors.forename: K
authors.initials: K
authors.lastname: Iglay
authors.affiliation: Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Qiu